Related Experiment Video
Updated: May 12, 2026
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine
Joseph L McClay1, Daniel E Adkins, Sarah A Vunck
1Center for Biomarker Research and Personalized Medicine, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, McGuire Hall, 1112 East Clay Street, Richmond, VA 23298-0533, USA.
This study used metabolomics to explore methamphetamine's effects on the rodent brain, identifying key metabolic changes and their link to behavior. The findings offer new insights into methamphetamine neurotoxicity and potential treatment targets.
Area of Science:
- Neuroscience
- Metabolomics
- Pharmacology
Background:
- Methamphetamine (MA) abuse has severe health consequences, with limited treatment options.
- Previous research focused on neurotransmitters, yielding insufficient therapeutic advancements.
- A metabolomic approach is needed to understand MA's broader neurochemical impact.
Purpose of the Study:
- To investigate the neurochemical consequences of acute and repeated methamphetamine exposure in the rodent brain using metabolomics.
- To identify specific metabolites associated with MA exposure and MA-induced behavioral changes.
- To develop a more comprehensive neurochemical model of MA's effects.
Main Methods:
- Utilized high-throughput gas and liquid chromatography-mass spectrometry (GC-MS and LC-MS) on rodent brain tissue.
- Analyzed over 300 unique metabolites following single and repeated (5-day) MA exposures (3 mg/kg).
- Employed association testing with false discovery rate control to identify significant metabolic changes.
Main Results:
- Identified significant acute MA-associated metabolites including lactate, tryptophan, and 2-hydroxyglutarate.
- Linked MA-induced locomotor activity to energy metabolites like succinate.
- Found repeated MA exposure associated with phosphocholine and ergothioneine, suggesting mitochondrial and antioxidant pathway involvement.
Conclusions:
- Metabolomics effectively identifies drug-induced alterations in brain metabolism.
- Findings support and extend models of MA neurotoxicity, involving energy metabolism, mitochondrial dysfunction, and antioxidant responses.
- This approach provides a powerful tool for understanding drug effects and developing novel therapeutic strategies for MA abuse.
